Cite

    Aihara, M. et al. (2017). Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients. Acta ophthalmologica. 95 (8), pp. e720-e726. [Online].